Global Canine Atopic Dermatitis Market Size & Outlook

The global canine atopic dermatitis market size was estimated at USD 3,852.9 million in 2024 and is projected to reach USD 6,686.6 million by 2030, growing at a CAGR of 9.8% from 2025 to 2030.
Revenue, 2024 (US$M)
$3,852.9
Forecast, 2030 (US$M)
$6,686.6
CAGR, 2025 - 2030
9.8%
Report Coverage
Worldwide

Global canine atopic dermatitis market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global canine atopic dermatitis market highlights

  • The global canine atopic dermatitis market generated a revenue of USD 3,852.9 million in 2024 and is expected to reach USD 6,686.6 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 9.8% by 2030.
  • In terms of segment, glucocorticoids accounted for a revenue of USD 1,598.8 million in 2024.
  • MAbs is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 3,852.9 million
Market revenue in 2030USD 6,686.6 million
Growth rate9.8% (CAGR from 2025 to 2030)
Largest segmentGlucocorticoids
Fastest growing segmentMAbs
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGlucocorticoids, Antihistamines, Immunosuppressants, MAbs

Other key industry trends

  • In terms of revenue, the North America accounted for 40.4% of the global canine atopic dermatitis market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, India is the fastest growing regional market and is projected to reach USD 208.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Canine Atopic Dermatitis Market Companies

Name Profile # Employees HQ Website
Dechra View profile - Shrewsbury, Shropshire, United Kingdom, Europe https://www.dechra.co.uk
Biofelix Pharma Group View profile 11-50 Ahmedabad, Gujarat, India, Asia https://biofelixgroup.com
Boehringer Ingelheim International GmbH View profile - - -
Merck & Co., Inc. View profile - - -
Elanco View profile 10001+ Greenfield, Indiana, United States, North America https://www.elanco.com
Bioiberica View profile 251-500 Barcelona, Catalonia, Spain, Europe https://www.bioiberica.com/
Bimeda View profile 1001-5000 Dublin, Dublin, Ireland, Europe https://www.bimeda.com/
Vetoquinol SA View profile 2483 Magny-Vernois, BP 189, Lure cedex, France, 70204 http://www.vetoquinol.com
Toray Industries Inc View profile 48682 Nihonbashi Mitsui Tower 2-1-1, Nihonbashi Muromach, Chuo-ku, Tokyo, Japan, 103-8666 http://www.toray.co.jp
CEVA Inc View profile 424 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 https://www.ceva-dsp.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

Global canine atopic dermatitis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to canine atopic dermatitis market will help companies and investors design strategic landscapes.


Glucocorticoids was the largest segment with a revenue share of 41.5% in 2024. Horizon Databook has segmented the Global canine atopic dermatitis market based on glucocorticoids, antihistamines, immunosuppressants, mabs covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Canine Atopic Dermatitis Product Outlook (Revenue, USD Million, 2018-2030)
    • Glucocorticoids
    • Antihistamines
    • Immunosuppressants
    • MAbs
    • Others
  • Global Canine Atopic Dermatitis Type Outlook (Revenue, USD Million, 2018-2030)
    • Prescription
    • OTC
  • Global Canine Atopic Dermatitis Dog Breed Outlook (Revenue, USD Million, 2018-2030)
    • German Shephard
    • Terriers
    • Retrievers
    • Other Breeds
  • Global Canine Atopic Dermatitis Mode of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Oral
    • Topical
    • Injectable
  • Global Canine Atopic Dermatitis Indication Outlook (Revenue, USD Million, 2018-2030)
    • Ectoparasites
    • Food Allergy
    • Allergic Skin Infections
    • Others
  • Global Canine Atopic Dermatitis Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Veterinary Hospitals/Clinics
    • Retail
    • E-Commerce

Reasons to subscribe to Global canine atopic dermatitis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global canine atopic dermatitis market databook

  • Our clientele includes a mix of canine atopic dermatitis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global canine atopic dermatitis market , including forecasts for subscribers. This global databook contains high-level insights into Global canine atopic dermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global canine atopic dermatitis market size, by regions, 2018-2030 (US$M)

Top 10 countries: Canine atopic dermatitis market size, 2024 (US$M)

Global canine atopic dermatitis market share, by product, 2024 & 2030 (%, US$M)

Canine atopic dermatitis market: Opportunity assessment by country

Global canine atopic dermatitis market, by region, 2024 (US$M)

Global canine atopic dermatitis market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online